All In Biotech

Drug Trial Radar · NCT07760467

To Evaluate Safety, Tolerability, PK/PD & Food Effect of Single/Multiple Oral TUL321 Capsules in Healthy Participants.

A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Characteristics of Single and Multiple Doses of TUL321 Capsule in Healthy Participants, and the Effect of Food on Pharmacokinetics

Last checked: Nov 20, 2026Latest source record: Sep 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

94

Planned (sponsor's estimate)

Start

Aug 26, 2026

Primary completion

May 8, 2027

Study completion May 8, 2027

Sponsor

Sponsor type
Industry
First posted
Aug 12, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Sequential
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Phase I Study Evaluating Safety, Tolerability, PK and PD of Single and Multiple Doses of TUL321 Capsule in Healthy Participants and Food Effect on PK

Conditions

  • Paroxysmal Nocturnal Hemoglobinuria, PNH

Interventions

  • Part1: TUL321Drug

    orally, 20 mg、50 mg、 100 mg、200 mg、400 mg and 600 mg

  • Part1: PlaceboDrug

    Oral placebo capsules matching TUL321 capsules

  • Part2: TUL321Drug

    orally, 50 mg QD、100 mg QD、300 mg QD、50 mg BID

  • Part2: PlaceboDrug

    Oral placebo capsules matching TUL321 capsules

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 1.Incidence of adverse events (AEs) 2.Changes from baseline in physical examinations, vital signs, electrocardiograms (ECG), and laboratory testsTime frame: up to 17 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Third Xiangya Hospital of Central South University

    Changsha, Hunan, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.